Magnesium sulphate versus dexmedetomidine for cough suppression during anesthetic emergence in smokers: A randomized double _ blind controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202308591985746

Enrollment

165

Registered

2023-08-17

Start date

2022-07-06

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

magnesium sulphate

dexmedetomidine

normal saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA 1,ASA 2 cigarette smokers age 21_60 years old patients performing lower abdominal surgeries

Exclusion criteria

Exclusion criteria: patients with history of pulmonary diseases patients under treatment with sedatives or beta blockers and angiotensin _ converting enzyme inhibitors any contraindication to use magnesium sulphate or dexmedetomidine

Design outcomes

Primary

Measure	Time frame
severity and incidence of cough	—

Secondary

Measure	Time frame
hemodynamic changes regarding blood pressure and heart rate , sedation degree	—

Countries

Egypt

Contacts

Public Contactmohamed ghoneim

lecturer

demerdash1975@gmail.com+201003969542

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026